General Information
Revision date
2021-09-04
Product name
Lisinopril / Hydrochlorothiazide Formulation
1.2.1 Relevant identified uses
Pharmaceutical
Emergency telephone
+1-908-423-6000
Icons in SDS
Company Information
company name
MSD
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@msd.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360D, H372
Hazard statements
Code
Statements
H360D
May damage the unborn child
Section 2
CLP CLASSIFICATION
Reproductive toxicity, Category 1A H360D: May damage the unborn child. Specific target organ toxicity - repeated H372: Causes damage to organs through pro- exposure, Category 1 longed or repeated exposure.
2.2 Label elements
REGULATION (EC) No 1272/2008)
Signal word
Danger
Hazard statements
H360D May damage the unborn child. H372 Causes damage to organs through prolonged or re- peated exposure.
Prevention
P201 Obtain special instructions before use. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Hazardous Ingredients
Hydrochlorothiazide Lisinopril
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. Dust contact with the eyes can lead to mechanical irritation. Contact with dust can cause mechanical irritation or drying of the skin. May form combustible dust concentrations in air during processing, handling or other means.
